Venetoclax in Combination With Azacitidine (VEN/AZA) Followed by Donor Lymphocyte Infusion (DLI) for Patients With Very High-Risk Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Conditions: Acute Myeloid Leukemia Interventions: Drug: Venetoclax; Drug: Azacitidine; Biological: Donor Lymphocyte Infusion Sponsors: Antonio M Jimenez Jimenez; AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials